Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Mabs|August 4, 2020
Bivalent binding on cells varies between anti-CD20 antibodies and is dose-dependentSina Bondza, Toine Ten Broeke, Marika Nestor, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|April 2, 2010
Blocking EGFR in the liver improves the tumor-to-liver uptake ratio of radiolabeled EGFHeewa Kareem, Karl Sandström, Ronny Elia, et al.
Frontiers in Oncology|October 17, 2019
The Stapled Peptide PM2 Stabilizes p53 Levels and Radiosensitizes Wild-Type p53 Cancer CellsAnja Charlotte Lundgren Mortensen, Diana Spiegelberg, Christopher John Brown, et al.
Frontiers in Oncology|April 18, 2022
In Vitro Characterization of 177Lu-DOTA-M5A Anti-Carcinoembryonic Antigen Humanized Antibody and HSP90 Inhibition for Potentiated Radioimmunotherapy of Colorectal CancerTabassom Mohajershojai, Preeti Jha, Anna Boström, et al.
Scientific Reports|April 5, 2020
The HSP90 inhibitor Onalespib exerts synergistic anti-cancer effects when combined with radiotherapy: an in vitro and in vivo approachDiana Spiegelberg, Andris Abramenkovs, Anja Charlotte Lundgren Mortensen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 3, 2015
Molecular imaging of EGFR and CD44v6 for prediction and response monitoring of HSP90 inhibition in an in vivo squamous cell carcinoma modelDiana Spiegelberg, Anja C Mortensen, Ram K Selvaraju, et al.
EJNMMI Research|April 18, 2020
Enhancing the therapeutic effects of in vitro targeted radionuclide therapy of 3D multicellular tumor spheroids using the novel stapled MDM2/X-p53 antagonist PM2Anja C L Mortensen, Eric Morin, Christopher J Brown, et al.
Cancers|September 9, 2023
Enhanced Therapeutic Effects of 177Lu-DOTA-M5A in Combination with Heat Shock Protein 90 Inhibitor Onalespib in Colorectal Cancer XenograftsTabassom Mohajershojai, Douglas Spangler, Saloni Chopra, et al.
Analytica Chimica Acta|January 18, 2017
The co-feature ratio, a novel method for the measurement of chromatographic and signal selectivity in LC-MS-based metabolomicsAlbert Elmsjö, Jakob Haglöf, Mikael K R Engskog, et al.
Oncotarget|October 10, 2015
The novel HSP90 inhibitor AT13387 potentiates radiation effects in squamous cell carcinoma and adenocarcinoma cellsDiana Spiegelberg, Adrian Dascalu, Anja C Mortensen, et al.
Pageof 7